Advertisement

Topics

Marker Gene Technologies, Inc. Company Profile

05:57 EST 18th December 2018 | BioPortfolio

Marker Gene Technologies,Inc is a primary supplier and developer of biopharmaceuticals, reagents and molecular biology products for use in medical research and industrial biotechnology. We strive for innovative, high-quality, timely, and environmentally responsible products that are of benefit to mankind. We commit to keeping Marker Gene Technologies,Inc a positive,fair, and fun workplace for all our employees.

Location

University of Oregon - Riverfront Research Park1850 Millrace Drive
Eugene
Oregon
97403-1992
United States of America

Contact

Phone: (541) 342-3760
Fax: (541) 342-1960
Email: unsubscribe@markergene.com


News Articles [1713 Associated News Articles listed on BioPortfolio]

American Gene Technologies: the first bio-safe gene delivery vector for human clinical therapeutic use

In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with Jeff Galvin, Chief Executive Officer at American Gene Technologies, a genetic research firm focusing on gene therap...

2018 Global Cell Surface Marker Testing Market: US, Europe, JapanSupplier Shares, Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review [Report Updated: 01011970] Prices from USD $4500

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergis...

2018 UK Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers [Report Updated: 01011970] Prices from USD $4750

HighlightsComprehensive 575page analysis of the UK tumor marker testing market.Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and techn...

2018 Italy Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers [Report Updated: 01011970] Prices from USD $4750

HighlightsComprehensive 570page analysis of the Italian tumor marker testing market.Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social...

2018 Japan Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers [Report Updated: 01011970] Prices from USD $4750

HighlightsComprehensive 590page analysis of the Japanese tumor marker testing market.Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, soci...

2018 Spain Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers [Report Updated: 01011970] Prices from USD $4750

HighlightsComprehensive 565page analysis of the Spanish tumor marker testing market.Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social...

2018 Germany Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers [Report Updated: 01011970] Prices from USD $4750

HighlightsComprehensive 585page analysis of the German tumor marker testing market.Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social a...

2018 US Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers [Report Updated: 01011970] Prices from USD $6500

Complete report $9,800. nbsp;DataPack test volumes, sales forecasts, supplier shares $6,400.HighlightsComprehensive 620page analysis of the US tumor marker testing market.Major issues pertaining to th...

PubMed Articles [2732 Associated PubMed Articles listed on BioPortfolio]

pheS* as a counter-selectable marker for marker-free genetic manipulations in Bacillus anthracis.

Several genetic tools have been developed for use in Bacillus anthracis, but there is still a need for a more marker-free gene inactivation protocols. Thus, we report a method to generate unmarked mut...

Unleashing the Therapeutic Potential of CAR-T Cell Therapy Using Gene-Editing Technologies.

Chimeric antigen receptor (CAR) T-cell therapy, an emerging immunotherapy, has demonstrated promising clinical results in hematological malignancies including B-cell malignancies. However, accessibili...

Gene Regulation in the 3D Genome.

The spatial organization of the genome is essential for the precise control of gene expression. Recent advances in sequencing and imaging technologies allow us to explore the 3D genome and its relatio...

Comprehensive evaluation of blood-brain barrier-forming micro-vasculatures: Reference and marker genes with cellular composition.

Primary brain microvessels (BrMV) maintain the cellular characters and molecular signatures as displayed in vivo, and serve as a vital tool for biomedical research of the blood-brain barrier (BBB) and...

RS7435335 located in the UGT2B7 gene may be a possible genetic marker for the clinical response and prognosis of breast cancer patients receiving neoadjuvant chemotherapy.

To evaluate the predictive efficacy and prognostic value of rs7435335 located in the UGT2B7 gene as a genetic marker in breast cancer patients receiving neoadjuvant chemotherapy (NAC).

Clinical Trials [3236 Associated Clinical Trials listed on BioPortfolio]

Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus

Given that GADD34 has been described as a potential key regulator of pro-inflammatory cytokine production in human and elevated blood marker in SLE patients, this study aim to prove that ...

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status

CENTRIC is a Phase III clinical trial assessing efficacy and safety of the investigational integrin inhibitor, cilengitide, in combination with standard treatment versus standard treatment...

Establishment of Comprehensive Genetic Analysis From a Single Cell

Preimplantation genetic diagnosis (PGD) is the integration of both assisted reproductive technologies and molecular genetic technologies and was shown to improve implantation rate and redu...

Procalcitonin (PCT) as a Diagnostic Marker of Bacterial Infection in the Patients Admitted for Fever and/or Inflammatory Syndrome to the Internal Medicine Department

Levels of PCT (a marker of bacterial infection) are highest during sepsis: in fact, PCT is normally produced by the C cells in the thyroid gland. PCT was initially studied by Assicot1 for ...

Magseed and Sentimag in Surgical Excision of Breast Lesions

The goal of this clinical research study is to learn more about the safety and effectiveness of a marker called Magseed that is used to help locate lesions during surgery. The Magseed mark...

Companies [1832 Associated Companies listed on BioPortfolio]

Marker Gene Technologies, Inc.

Marker Gene Technologies,Inc is a primary supplier and developer of biopharmaceuticals, reagents and molecular biology products for use in medical research and industrial biotechnology. We strive for ...

Marker Test Diagnostics

Founded in 2013, Marker Test Diagnostics is the producer of UR Code (TM), an innovative oral marker for the drug testing market. Marker Test Diagnostics is currently conducting re...

Marker Test Diagnostics, Inc.

Founded in 2013, Marker Test Diagnostics is the producer of UR Code (TM), an innovative urine marker for the drug testing market. Marker Test Diagnostics has completed research st...

GeneQuest Diagnostics™

GeneQuest Diagnostics™ provides state-of-the-art analysis of DNA based forensic and paternity procedures.We are in the process of developing chip (Gene Chip™) and micro array (Gene Array™) based...

Gene Expression Technologies

Gene Expression Technologies Limited (GET) is a biopharmaceutical company established to develop and commercialise Gene ICE™, a unique and proprietary platform for gene expression regulation. This t...

More Information about "Marker Gene Technologies, Inc." on BioPortfolio

We have published hundreds of Marker Gene Technologies, Inc. news stories on BioPortfolio along with dozens of Marker Gene Technologies, Inc. Clinical Trials and PubMed Articles about Marker Gene Technologies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Marker Gene Technologies, Inc. Companies in our database. You can also find out about relevant Marker Gene Technologies, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record